Skip to main content

Teva Pharmaceutical Value Stock - Dividend - Research Selection

Teva Pharmaceutical

ISIN: US8816242098, WKN: 883035

Market price date: 27.05.2021
Market price: 10,38 USD

Teva Pharmaceutical Fundamental data and company key figures of the share

Annual reports in USD
Key figures 25-02-2021
Cash flow
Net operating cash flow
Capital Expenditures -578.000.000
Free cash flow 638.000.000
Balance sheet
Total Equity
Liabilities & Shareholders equity 50.640.000.000
Income statement
Net income -3.990.000.000
Eps (diluted) -0,916
Diluted shares outstanding
Net sales/revenue 16.659.000.000

Fundamental ratios calculated on: 27-05-2021

Key figures 27-05-2021
Cash flow
P/C 9,56
P/FC 17,82
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization11.628.900.352,00 USD
Raw Data SourceUS GAAP in Millionen USD
Stock Split2004-07-02,2.0000/1.0000; 2004-07-01,2.0000/1.0000; 2002-12-07,2.0000/1.0000; 2002-12-06,2.0000/1.0000; 2000-02-24,2.0000/1.0000; 2000-02-23,2.0000/1.0000; 2000-02-22,1.0000/1.0000; 1993-04-15,2.0000/1.0000; 1993-04-14,2.0000/1.0000; 1982-08-16,1.000000/1.000000

Description of the company

Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. Teva´s active pharmaceutical ingredient (API) business provides vertical integration to Teva´s own pharmaceutical production. The Company´s global operations are conducted from North and Latin America to Europe and Asia. Teva operates a number of subsidiaries in such countries as Canada, Croatia, the Czech Republic, France, Germany, Hungary, Ireland, Israel, Japan, Poland, the Russian Federation, Spain, the Netherlands, the United Kingdom and the United States.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,